# 바이오스페이스 일일 뉴스 리포트 - 2025년 06월 17일


## 주요 헤드라인

1. **NextCure Joins China-ADC Gold Rush with $745M Simcere Deal (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/nextcure-joins-china-adc-gold-rush-with-745m-simcere-deal>

2. **NextCure Joins China-ADC Gold Rush with $745M Simcere Deal (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/nextcure-joins-china-adc-gold-rush-with-745m-simcere-deal>

3. **Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/partner-seeking-biotechs-find-plenty-of-hands-to-shake-as-bio2025-kicks-off>

4. **Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/partner-seeking-biotechs-find-plenty-of-hands-to-shake-as-bio2025-kicks-off>

5. **Lilly Notches ‘Top-Tier’ Weight Loss Results for Phase I Amylin/Tirzepatide Combo (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-notches-top-tier-weight-loss-results-for-phase-i-amylin-tirzepatide-combo>

6. **Roche, Prothena Push Parkinson’s Drug to Phase III Despite Mid-Stage Fail (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/roche-prothena-push-parkinsons-drug-to-phase-iii-despite-mid-stage-fail>

7. **Regeneron Backs Off 23andMe, Losing Bid to Former CEO (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/regeneron-backs-off-23andme-losing-bid-to-former-ceo>


---
*2025년 06월 17일 바이오스페이스 뉴스 피드에서 생성된 리포트*